Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study

被引：0
|
作者：
Reis, D. [1 ]
Mendes, A. [1 ]
China, N. [1 ]
Dias, M. [1 ]
Coutinho, D. [1 ]
Silva, E. [1 ]
Campainha, S. [1 ]
Costa, T. [1 ]
Conde, S. [1 ]
Barroso, A. [1 ]
机构：
[1] Vila Nova de Gaia Espinho Hosp Ctr, Vila Nova De Gaia, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
nivolumab; Lung cancer;
D O I：
10.1016/j.jtho.2019.08.2140
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.04-10
引用
收藏
页码：S975 / S976
页数：2
相关论文
共 50 条
  • [1] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): The Real-Life Data
    Dudnik, Elizabeth
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Bar, Jair
    Merimsky, Ofer
    Cyjon, Arnold
    Shochat, Tzippy
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S417 - S418
  • [2] Nivolumab for Non-Small Cell Lung Cancer (NSCLC): An Economic Model for Risk Sharing Based on Real-Life Data
    Dudnik, Elizabeth
    Goldstein, Daniel
    Roisman, Laila
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Bar, Jair
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Merimsky, Ofer
    Cyjon, Arnold
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1432 - S1433
  • [3] Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data
    Dudnik, Elizabeth
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Grubstein, Ahuva
    Shochat, Tzippy
    Wollner, Mira
    Bar, Jair
    Merimsky, Ofer
    Zer, Alona
    Goldstein, Daniel A.
    Hammerman, Ariel
    Cyjon, Arnold
    Shechtman, Yelena
    Abu-Amna, Mahmood
    Flex, Dov
    Roisman, Laila C.
    Peled, Nir
    LUNG CANCER, 2018, 126 : 217 - 223
  • [4] Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study
    Perol, M.
    Dixmier, A.
    Barlesi, F.
    Debieuvre, D.
    Raspaud, C.
    Auliac, J. B.
    Benoit, N.
    Bombaron, P.
    Moro-Sibilot, D.
    Asselain, B.
    Cotte, F-E.
    Lamoureux, P.
    Karam, N.
    Ozan, N.
    Calvet, C.
    Bryan, B.
    Allan, V.
    Valette, C. Audigier
    ANNALS OF ONCOLOGY, 2019, 30 : 46 - 46
  • [5] Radiotherapy (RT) and Nivolumab in Non-Small-Cell Lung Cancer (NSCLC): A Multicenter Real-Life Experience
    Bassanelli, M.
    Giannarelli, D.
    Ricciuti, B.
    Magri, V.
    Cecere, F. L.
    Roberto, M.
    Giacinti, S.
    Barucca, V.
    Cassese, R.
    De Giglio, A.
    Scagnoli, S.
    Milella, M.
    Santarelli, M.
    Bengala, C.
    Ruggeri, E. M.
    Marchetti, P.
    Cognetti, F.
    Gelibter, A.
    Cortesi, E.
    Chiari, R.
    Ceribelli, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S611 - S611
  • [6] Real-Life Intracerebral Efficacy of Nivolumab in Non-Small Cell Lung Cancer Patients with Brain Metastases
    Geier, M.
    Descourt, R.
    Corre, R.
    Leveiller, G.
    Lamy, R.
    Goarant, E.
    Bizec, J.
    Bernier, C.
    Quere, G.
    Couturaud, F.
    Robinet, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S384 - S385
  • [7] Economic aspects of nivolumab in non-small cell lung cancer (NSCLC): Lessons from real life.
    Dudnik, Elizabeth
    Roisman, Laila
    Bar, Jair
    Peled, Nir
    Hammerman, Ariel
    Daher, Sameh
    Moskovitz, Mor Tal
    Shama, Sivan
    Hanovich, Ekaterina
    Zer, Alona
    Merimsky, Ofer
    Wollner, Mira
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] IFCT-1502 CLINIVO: Real-Life Experience with Nivolumab in 600 Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Molinier, O.
    Audigier-Valette, C.
    Cadranel, J.
    Monnet, I.
    Hureaux, J.
    Hilgers, W.
    Fauchon, E.
    Fabre, E.
    Besse, B.
    Brun, P.
    Coetmeur, D.
    Quoix, E.
    Mourlanette, P.
    Barlesi, F.
    Bordenave-Caffre, S.
    Egenod, T.
    Missy, P.
    Morin, F.
    Moro-Sibilot, D.
    Girard, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1793 - S1793
  • [9] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [10] Nivolumab treatment in advanced non-small cell lung cancer (NSCLC): Retrospective analysis of real-life data in the Hospital Universitario Reina Sofia (HURS).
    GarcAa DurAin, Carmen
    Moreno-Vega, Alberto L.
    Sanchez Maurino, Pedro
    Lopez-Gonzalez, Javier
    Barneto-Aranda, Isidoro C.
    De La Haba, Juan
    Aranda Aguilar, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
12345